603235.SHG JiangXi Tianxin Pharm Co Ltd
- Market cap
- CNY 10.9B
- P/E
- 19.7x
- P/B
- 2.13x
- ROE
- 11.0%
- Dividend yield
- 2.80%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603235.SHG undervalued?
Graham number603235.SHG trades 36.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
JiangXi Tianxin Pharm Co Ltd fundamental analysis
No fundamental analysis for JiangXi Tianxin Pharm Co Ltd yet.
JiangXi Tianxin Pharm Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About JiangXi Tianxin Pharm Co Ltd
JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers vitamin B6, vitamin B1, vitamin B5, vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, a-acetyl-"-butyrolactone, ABL, cholesterol, L-alanine, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co.,…
Full company profileJiangXi Tianxin Pharm Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
JiangXi Tianxin Pharm Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 2.30B | 2.52B | 2.30B | 1.88B | 2.21B | 2.35B | 2.49B |
| Gross Profit | 1.25B | 1.09B | 858M | 720M | 928M | 992M | 1.05B |
| Operating Income | 1.13B | 927M | 625M | 467M | 668M | 689M | 696M |
| EBITDA | - | - | 860M | 706M | 928M | 895M | 677M |
| Net Income | 887M | 744M | 622M | 476M | 651M | 592M | 560M |
| EPS | 2.25 | 1.89 | 1.42 | 1.09 | 1.49 | 1.35 | 1.28 |
| Balance Sheet | |||||||
| Total Assets | 2.92B | 2.95B | 4.68B | 5.09B | 5.60B | 6.19B | 6.46B |
| Total Liabilities | 1.76B | 1.04B | 622M | 857M | 987M | 1.27B | 1.36B |
| Shareholders' Equity | 1.15B | 1.91B | 4.06B | 4.23B | 4.62B | 4.92B | 5.10B |
| Cash & Short-term Investments | 1.02B | 717M | 2.07B | 2.31B | 1.08B | 1.57B | 1.76B |
| Cash Flow | |||||||
| Operating Cash Flow | 1.16B | 819M | 607M | 729M | 500M | 629M | - |
| Capital Expenditure | 303M | 216M | 260M | 536M | 1.07B | 581M | 307M |
| Free Cash Flow | 861M | 603M | 346M | 194M | -567M | 48.7M | 452M |
| Ratios | |||||||
| ROE | 76.8% | 39.0% | 15.3% | 11.2% | 14.1% | 12.0% | 11.0% |
| ROA | 30.4% | 25.2% | 13.3% | 9.3% | 11.6% | 9.6% | 8.7% |
| Net Profit Margin | 38.5% | 29.5% | 27.0% | 25.3% | 29.5% | 25.2% | 22.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
JiangXi Tianxin Pharm Co Ltd dividends
- Dividend yield
- 2.80%
- Forward dividend
- 0.55 CNY
- Payout ratio
- 51.5%
- Ex-dividend date
- Jul 1, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 305M | 0.70 | 51.5% |
| 2024 | CNY 220M | 0.50 | 33.8% |
| 2023 | CNY 312M | 0.71 | 65.7% |
| 2022 | CNY 6.83M | 0.02 | 1.1% |
| 2021 | CNY 878M | 2.23 | 118.1% |
| 2020 | CNY 853M | 2.17 | 96.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns JiangXi Tianxin Pharm Co Ltd
- Insiders 91.65%
- Institutions 0.10%
- Public & others 8.26%
- Shares outstanding 438M
- Free float 41.2M
JiangXi Tianxin Pharm Co Ltd company profile
- Company name
- JiangXi Tianxin Pharm Co Ltd
- Ticker
- 603235.SHG
- ISIN
- CNE100005Q89
- Exchange
- Shanghai Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 2,893
- Fiscal year end
- December
- Address
- Leping Industrial Park, Leping, China, 333300
- Phone
- 86 79 8670 2222
- Website
- txpharm.com
About JiangXi Tianxin Pharm Co Ltd
JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers vitamin B6, vitamin B1, vitamin B5, vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, a-acetyl-"-butyrolactone, ABL, cholesterol, L-alanine, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co., Ltd. was founded in 2004 and is based in Leping, China.
JiangXi Tianxin Pharm Co Ltd management
5- Mr. Xiaobing YuaGM & Director · born 1981
- Mr. Xuelin LuoCFO & Financial Director · born 1974
- Mr. Yi DongBoard Secretary · born 1988
- Mr. Shengyang LiDeputy General Manager · born 1981
- Liang LiangAccounting Supervisor